Approval · Notice of Compliance 292 · 2004
ZAVESCA: Notice of Compliance 292
Issued March 31, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 292
- Date
- March 31, 2004
- Company
- Actelion Pharmaceuticals LtdAllschwil, Basel-Landschaft, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Glucosyceramide synthase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZAVESCA | 02250519 | Marketed |
Medicinal ingredients
- MIGLUSTAT 100 MG per CAP